The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ex-vivo sensitivity-directed combination chemotherapy compared to DTIC monochemotherapy in chemo-naive advanced metastastic melanoma (ChemoSensMM): A multicenter randomized phase-3 DeCOG trial.
 
Selma Ugurel
Honoraria - Bristol-Myers Squibb; Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Research Funding - Medac (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche Pharma AG
 
Carmen Loquai
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche Pharma AG
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche Pharma AG
 
Patrick Terheyden
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
 
Dirk Schadendorf
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Research Funding - Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche Pharma AG
 
Erika Richtig
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche Pharma AG
 
Jochen Utikal
Consulting or Advisory Role - GlaxoSmithKline; Roche Pharma AG
Speakers' Bureau - GlaxoSmithKline; Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Ralf Gutzmer
Honoraria - Almirall Hermal GmbH; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Galderma; GlaxoSmithKline; Novartis; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; LEO Pharma; Merck Sharp & Dohme; Novartis; Pfizer; Roche Pharma AG
Research Funding - Johnson & Johnson; Novartis; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche Pharma AG
 
Knuth Rass
Honoraria - Covidien
Travel, Accommodations, Expenses - Covidien; Ofa Bamberg
 
Cord Sunderkötter
No Relationships to Disclose
 
Annette Stein
No Relationships to Disclose
 
Michael Fluck
Consulting or Advisory Role - Merck Sharp & Dohme; Roche Pharma AG
Research Funding - Novartis; Roche Pharma AG
 
Martin Kaatz
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Expert Testimony - Amgen; Bristol-Myers Squibb; Novartis; Roche Pharma AG
 
Uwe Trefzer
No Relationships to Disclose
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche Pharma AG
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); GlaxoSmithKline (Inst); MELA Sciences (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); OncoSec (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche Pharma AG
 
Rudolf Stadler
Consulting or Advisory Role - Galderma; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Galderma
 
Carola Berking
Honoraria - Almirall Hermal GmbH; Biofrontera; Bristol-Myers Squibb; Galderma; GlaxoSmithKline; LEO Pharma; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Consulting or Advisory Role - Almirall Hermal GmbH; Amgen; AstraZeneca; Biofrontera; Bristol-Myers Squibb; Galderma; GlaxoSmithKline; LEO Pharma; Merck Sharp & Dohme; Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Roche Pharma AG
 
Hubert E. Pehamberger
No Relationships to Disclose
 
Annette Kopp-Schneider
No Relationships to Disclose
 
Jürgen C. Becker
Honoraria - Amgen; Novartis
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Novartis
Speakers' Bureau - Amgen
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Sharp & Dohme